G09 - IBC and IRB Collaboration: Working Together for Safety and Oversight

CLICK HERE to view captioning for this session! 

As institutions increase the number of human gene therapy trials, it is important for biosafety officers and IBC administrators to understand the role of the IRB, and vice versa. With a common understanding of roles, these professionals can more thoroughly address how best to work together. IBCs and IACUCs have worked closely together for many years. However, as therapies move from pre-clinical animal studies into human trials, the IBC needs to be equally as connected with the IRB where the review dynamics, risks for participants, and overall focus of the oversight changes. In this session, speakers from local research institutions will discuss how they work collaboratively between the IBC and IRB to advance research through the start-up process and ensure ongoing safety and ethical oversight of human gene therapy trials and other research involving genetically engineered materials.